| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Aug 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 135.61M | 141.86M | 152.75M | 152.91M | 101.31M |
| Gross Profit | 13.88M | 17.86M | 18.60M | 18.35M | 9.63M |
| EBITDA | 16.62M | 15.75M | 14.14M | 14.24M | 13.05M |
| Net Income | 2.28M | 6.10M | 4.62M | 4.60M | 5.82M |
Balance Sheet | |||||
| Total Assets | 155.41M | 157.42M | 161.57M | 177.94M | 149.64M |
| Cash, Cash Equivalents and Short-Term Investments | 23.36M | 20.48M | 27.95M | 34.73M | 13.96M |
| Total Debt | 34.28M | 34.58M | 34.72M | 36.39M | 35.93M |
| Total Liabilities | 73.05M | 73.26M | 81.95M | 101.26M | 78.15M |
| Stockholders Equity | 82.36M | 84.16M | 79.62M | 76.68M | 71.49M |
Cash Flow | |||||
| Free Cash Flow | 10.71M | 5.33M | 4.65M | 21.28M | 19.30M |
| Operating Cash Flow | 12.11M | 5.94M | 5.18M | 22.06M | 20.47M |
| Investing Cash Flow | 1.21M | 1.29M | 1.49M | 6.67M | -5.87M |
| Financing Cash Flow | -9.69M | -15.05M | -12.08M | -10.60M | -15.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.51B | 17.05 | 16.69% | 1.27% | 1.69% | 276.44% | |
75 Outperform | £1.48B | 21.14 | 12.93% | 2.89% | -4.54% | -22.81% | |
64 Neutral | £77.68M | 33.01 | 2.74% | 2.25% | -4.40% | -62.70% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | £252.33M | -55.70 | -2.37% | ― | -9.89% | -109.47% | |
42 Neutral | £80.27M | -8.83 | -5.70% | 0.90% | 8.64% | -143.74% | |
40 Underperform | £7.40M | -0.20 | -52.46% | ― | 11.78% | -39.58% |